Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7653665 | 0.89 | BCAT1 (0.72) | BCAT1BCAT2 | |
| SCHEMBL6700098 | 0.87 | BCAT1 (0.82) | BCAT1BCAT2 | |
| SCHEMBL6696068 | 0.85 | BCAT1 (0.73) | BCAT1BCAT2 | |
| SCHEMBL29779261 | 0.84 | BCAT1 (1.00) | BCAT1BCAT2 | |
| SCHEMBL29779361 | 0.84 | BCAT1 (0.84) | BCAT1BCAT2 | |
| SCHEMBL24825974 | 0.84 | BCAT1 (1.00) | BCAT1BCAT2 | |
| SCHEMBL24825580 | 0.84 | BCAT1 (0.84) | BCAT1BCAT2 | |
| SCHEMBL24824016 | 0.83 | BCAT1 (1.00) | BCAT1BCAT2 | |
| SCHEMBL24823997 | 0.83 | BCAT1 (1.00) | BCAT1BCAT2 | |
| SCHEMBL29779240 | 0.83 | BCAT1 (1.00) | BCAT1BCAT2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1095027-B1 | SUBSTITUTED PHENYL URACILS | BAYER CROPSCIENCE AG (DE) | 2005-06-15 | — | — | EP | disclosed |
| US-20040254206-A1 | Substituted phenyluracils | ANDREE ROLAND (DE) | 2004-12-16 | — | — | US | disclosed |
| US-6815398-B1 | PRE- AND POSTEMERGENCE HERBICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 2004-11-09 | — | — | US | disclosed |
| US-6780821-B1 | HERBICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 2004-08-24 | — | — | US | disclosed |
| EP-1242387-A1 | SUBSTITUTED PHENYLURACILS AND THEIR USE AS HERBICIDES | Bayer Aktiengesellschaft (DE) | 2002-09-25 | — | — | EP | disclosed |
| WO-2001034575-A1 | SUBSTITUTED PHENYLURACILS AND THEIR USE AS HERBICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 2001-05-17 | — | — | WO | disclosed |
| EP-1095027-A1 | SUBSTITUTED PHENYL URACILS | BAYER AG (DE) | 2001-05-02 | — | — | EP | disclosed |
| WO-2000002866-A1 | SUBSTITUTED PHENYL URACILS | BAYER AKTIENGESELLSCHAFT (DE) | 2000-01-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040254206-A1 | Substituted phenyluracils | DPYD, NDUFS5, POP1 | BCAT1 819/4885BCAT2 664/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.